MegaPro Biomedical Co., Ltd.
Update:2026/01/07
Industries
Main Industry
Biotechnology
Main Product/Service
1. Current Progress of Product Development
2. MPB-1514
3. MPB-1523 (IOP Injection)
4. MPB-1734: A New Formulation Anti-cancer Drug
2. MPB-1514
3. MPB-1523 (IOP Injection)
4. MPB-1734: A New Formulation Anti-cancer Drug
Founded Year
2014
Unified Business No.
24765568
Status
Active
Number of Employees
0
Total Paid-in
Capital
795,239,030 (NT$)
Location of Company
Taiwan
, Hsinchu County
Exit Status
Emerging Stock Exchange(2021)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
MegaPro Biomedical Co., Ltd.'s main product is mainly the nano iron oxide.
Based on the core team that developed nano-iron oxide products in the Industrial Technology Research Institute, the company is established to focus on the development of nic
Based on the core team that developed nano-iron oxide products in the Industrial Technology Research Institute, the company is established to focus on the development of nic